生脉注射液治疗老年难治性心衰的临床观察

Clinical Study on the Effect of Sheng Mai Injection on Refractory Heart Failure of Senile Patients

目的观察生脉注射液治疗老年难治性心衰的临床疗效和不良反应。方法将临床确诊为老年难治性心力衰竭患者按心功能NYHA分级标准进行分级8,0例患者随机分为对照组(40例),观察组(40例),对照组予以常规西药治疗,观察组在西药常规治疗的基础上给予生脉注射液治疗,疗程结束后对两组的临床效果进行比较。结果两组患者临床症状﹑多普勒超声心动图﹑疗效比较有显著性差异(p<0.01),观察组无明显不良反应,综合疗效优于对照组。结论生脉注射液联合西药常规治疗,能更有效纠正心衰,改善心功能,且无明显不良反应。

Objective To observe the clinical curative effect and the side effect of Sheng Mai Injection on refractory heart failure of senile patients. Methods 80 senile patients with refractory heart failure final-diagnosed clinically were classified according to NYHA and were divided randomly into 2 groups： observation group and control group,40 in each;routine western medicine treatment was given to patients in both groups while Sheng Mai Injection was given to patients in observation group in addition;after treatment,the clinical effects of the 2 groups were compared. Result The contrast study of clinical symptoms,Doppler echocardiography and the curative effect indicated a significant difference between the 2 groups（P0.01）;no obvious side effect was found in observation group and its general curative effect was superior to that of control group. Conclusions Sheng Mai Injjection,combined with routine western medicine treatment,is more effective on heart failure and in improving heart function;it causes no obvious side effect.